BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38145655)

  • 21. ECM Cross-Linking Regulates Invadopodia Dynamics.
    Pourfarhangi KE; Bergman A; Gligorijevic B
    Biophys J; 2018 Mar; 114(6):1455-1466. PubMed ID: 29590602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation.
    Ninio L; Nissani A; Meirson T; Domovitz T; Genna A; Twafra S; Srikanth KD; Dabour R; Avraham E; Davidovich A; Gil-Henn H; Gal-Tanamy M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
    Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
    J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.
    Bowden ET; Onikoyi E; Slack R; Myoui A; Yoneda T; Yamada KM; Mueller SC
    Exp Cell Res; 2006 May; 312(8):1240-53. PubMed ID: 16442522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca
    Xue Y; Li M; Hu J; Song Y; Guo W; Miao C; Ge D; Hou Y; Wang X; Huang X; Liu T; Zhang X; Huang Q
    Cell Death Dis; 2022 Sep; 13(9):812. PubMed ID: 36137995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β1 integrin-mediated signaling regulates MT1-MMP phosphorylation to promote tumor cell invasion.
    Grafinger OR; Gorshtein G; Stirling T; Brasher MI; Coppolino MG
    J Cell Sci; 2020 May; 133(9):. PubMed ID: 32205364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EB1 Restricts Breast Cancer Cell Invadopodia Formation and Matrix Proteolysis via FAK.
    Chanez B; Ostacolo K; Badache A; Thuault S
    Cells; 2021 Feb; 10(2):. PubMed ID: 33668531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
    Peláez R; Morales X; Salvo E; Garasa S; Ortiz de Solórzano C; Martínez A; Larrayoz IM; Rouzaut A
    PLoS One; 2017; 12(8):e0181579. PubMed ID: 28767724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1.
    Dong Y; Xie X; Wang Z; Hu C; Zheng Q; Wang Y; Chen R; Xue T; Chen J; Gao D; Wu W; Ren Z; Cui J
    Biochem Biophys Res Commun; 2014 Feb; 444(3):427-32. PubMed ID: 24472554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion.
    Sedgwick AE; Clancy JW; Olivia Balmert M; D'Souza-Schorey C
    Sci Rep; 2015 Oct; 5():14748. PubMed ID: 26458510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation.
    Ren XL; Qiao YD; Li JY; Li XM; Zhang D; Zhang XJ; Zhu XH; Zhou WJ; Shi J; Wang W; Liao WT; Ding YQ; Liang L
    Cancer Lett; 2018 Apr; 419():245-256. PubMed ID: 29374558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting the functional domain requirements of cortactin in invadopodia formation.
    Webb BA; Jia L; Eves R; Mak AS
    Eur J Cell Biol; 2007 Apr; 86(4):189-206. PubMed ID: 17343955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERβ promoted invadopodia formation-mediated non-small cell lung cancer metastasis via the ICAM1/p-Src/p-Cortactin signaling pathway.
    Wang Y; Qiu W; Chen J; Meng W; Zhao R; Lin W; Mei P; Diao M; Xiao H; Liao Y
    Int J Cancer; 2023 Sep; 153(6):1287-1299. PubMed ID: 37212571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Invadopodium Formation and Gelatin Degradation in Vitro.
    Clarke MJ; Battagin S; Coppolino MG
    Methods Mol Biol; 2024; 2747():141-149. PubMed ID: 38038938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation.
    Ayala I; Baldassarre M; Giacchetti G; Caldieri G; Tetè S; Luini A; Buccione R
    J Cell Sci; 2008 Feb; 121(Pt 3):369-78. PubMed ID: 18198194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-lymphoma invasion and metastasis 1 promotes invadopodia formation and is regulated by the PI3K/Akt signaling pathway in hepatocellular carcinoma.
    Wang B; Zheng B; Cao L; Liao K; Huang D; Zhang Y; Jiang Y; Zheng S
    Exp Cell Res; 2021 Oct; 407(2):112806. PubMed ID: 34487727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation.
    Peng X; Li X; Yang S; Huang M; Wei S; Ma Y; Li Y; Wu B; Jin H; Li B; Tang S; Fan Q; Liu J; Yang L; Li H
    J Exp Clin Cancer Res; 2021 Jun; 40(1):183. PubMed ID: 34088337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
    Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
    Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
    [No Abstract]   [Full Text] [Related]  

  • 40. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES; Whigham AS; Yarbrough WG; Weaver AM
    Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.